We have shown that the postmortem frontal cortex tissue from AD patients has notably increased protein levels of neuroserpin, the endogenous tPA inhibitor, leading to decreased tPA protein levels and activity resulting in lower plasmin brain content [98,106,109]. This evidence concerns the gene PLAT and Alzheimer disease.